GlassScriptPhysician profile
Chee H Kim
NPI 1013974245
$266,018.76
in general payments reported to CMS, 2019-2025
21 companies · $70K in 2025
The $70K reported for 2025 was more than what 99% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41K · 2020: $21K · 2021: $19K · 2022: $29K · 2023: $36K · 2024: $49K · 2025: $70K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $92K · Consulting Fee: $34K · Travel and Lodging: $18K · Food and Beverage: $11K · Education: $24.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $92,400.02 |
| Consulting Fee | $34,125.00 |
| Travel and Lodging | $17,999.71 |
| Food and Beverage | $10,655.13 |
| Education | $24.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $151,263.73 | 2019-2025 | General - Ep, Farapulse, General - Therapies |
| Medtronic, INC. | $66,972.35 | 2021-2025 | Micra, Affera Mapping System, Diamondtemp Bidirectional Ablation Catheter |
| Medtronic Vascular, INC. | $41,309.63 | 2019-2020 | |
| Abbott Laboratories | $2,760.76 | 2019-2025 | Aveir, Ensite, Tacticath Ablation Catheter, Sensor Enabled |
| Impulse Dynamics (USA) INC. | $2,108.07 | 2022-2025 | Optimizer, Optimizer |
| Kestra Medical Technology Services, INC. | $480.25 | 2023-2025 | Assure Wcd |
| Janssen Pharmaceuticals, INC | $237.42 | 2019-2022 | |
| Pfizer INC. | $172.47 | 2019-2024 | |
| Irhythm Technologies, INC. | $165.18 | 2023 | Zio Xt Patch |
| E.R. Squibb & Sons, L.L.C. | $98.41 | 2019-2025 | Eliquis, Camzyos |
| Merck Sharp & Dohme LLC | $93.18 | 2022-2024 | Verquvo |
| Amgen INC. | $88.94 | 2019-2020 | |
| Cardiva Medical, INC. | $57.41 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Novartis Pharmaceuticals Corporation | $54.17 | 2019-2024 | |
| Sanofi-Aventis U.S. LLC | $38.49 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $27.18 | 2024 | Inspire |
| Cordis US Corp. | $24.11 | 2024 | Mynx Venous Vcd |
| Kiniksa Pharmaceuticals, LTD. | $20.31 | 2023 | Arcalyst |
| Lantheus Medical Imaging, INC. | $17.80 | 2023 | Definity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.65 | 2023 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $12.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chee Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.